Image Newsroom NASTAD In the News What is xylazine, and how is it contributing to overdose deaths? Mar 28, 2023 An Evaluation of the Successes of the NASTAD Minority Leadership Program and Its Implications for Leadership in State Health Departments Mar 24, 2023 Emory Launches Program to Deliver 1 Million Rapid HIV Self-tests Across the Country Mar 21, 2023 Blog Strengthening Immunization Efforts: NASTAD's Partnership with CDC for National Immunization Awareness Month and Back to School Campaign Aug 29, 2023 Read more CDC Issues 2021 Viral Hepatitis Surveillance Report Aug 23, 2023 Read more Enhancing Harm Reduction and PrEP/PEP Services Through Community Pharmacies Aug 17, 2023 NASTAD Recommendations for Cluster and Outbreak Detection and Response & Molecular HIV Surveillance Aug 2, 2023 See all blog posts Press Releases New Assessment Highlights Legal Authority of Pharmacists to Provide Access to Vital HIV and Harm Reduction Services Across U.S. Aug 17, 2023 Read more NASTAD Condemns LHHS Appropriations Bill that Would Cut Millions from Vital HIV/AIDS Prevention and Treatment Programs Jul 14, 2023 Read more NASTAD Awards $6 Million to Syringe Services Programs (SSPs) and Harm Reduction Organizations Apr 7, 2023 End of Mandatory Coverage of PrEP by Insurers Puts Lives at Risk Mar 31, 2023 See all press releases Newsletters Ending the HIV Epidemic Newsletter Sep 26, 2023 Read more Policy Updates: Hill Happenings and Administration Activities Sep 25, 2023 Read more Hepatitis Happenings and Updates Sep 25, 2023 Policy Updates: Hill Happenings and Administration Activities Sep 18, 2023 See all newsletters
An Evaluation of the Successes of the NASTAD Minority Leadership Program and Its Implications for Leadership in State Health Departments Mar 24, 2023
Strengthening Immunization Efforts: NASTAD's Partnership with CDC for National Immunization Awareness Month and Back to School Campaign Aug 29, 2023 Read more
NASTAD Recommendations for Cluster and Outbreak Detection and Response & Molecular HIV Surveillance Aug 2, 2023
New Assessment Highlights Legal Authority of Pharmacists to Provide Access to Vital HIV and Harm Reduction Services Across U.S. Aug 17, 2023 Read more
NASTAD Condemns LHHS Appropriations Bill that Would Cut Millions from Vital HIV/AIDS Prevention and Treatment Programs Jul 14, 2023 Read more
NASTAD Awards $6 Million to Syringe Services Programs (SSPs) and Harm Reduction Organizations Apr 7, 2023